Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2017, Article ID 1262309, 13 pages
https://doi.org/10.1155/2017/1262309
Research Article

Hybrids of Iron-Filled Multiwall Carbon Nanotubes and Anticancer Agents as Potential Magnetic Drug Delivery Systems: In Vitro Studies against Human Melanoma, Colon Carcinoma, and Colon Adenocarcinoma

1Department of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Silesian University of Technology, Krzywoustego 4, 44-100 Gliwice, Poland
2Biosystems Group Department of Automatics, Electronics and Informatics, Institute of Automatic Control, Silesian University of Technology, Akademicka 16, Gliwice, Poland
3NanoBioMedical Centre, Adam Mickiewicz University in Poznań, Umultowska 85, 61-614 Poznań, Poland
4Mössbauer Spectroscopy Laboratory, Institute of Physics, Pedagogical University, Podchorążych 2, 30-084 Kraków, Poland

Correspondence should be addressed to Sławomir Boncel; lp.lslop@lecnob.rimowals

Received 17 January 2017; Revised 9 April 2017; Accepted 15 June 2017; Published 31 July 2017

Academic Editor: Raul Arenal

Copyright © 2017 Sławomir Boncel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2016,” CA: A Cancer Journal for Clinicians, vol. 66, no. 1, pp. 7–30, 2016. View at Publisher · View at Google Scholar
  2. A. Schroeder, D. A. Heller, M. M. Winslow et al., “Treating metastatic cancer with nanotechnology,” Nature Reviews Cancer, vol. 12, no. 1, pp. 39–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. World Health Organization, World Cancer Report 2014, chapter 1.1, 2014.
  4. A. P. Nikalje, “Nanotechnology and its applications in medicine,” Medicinal Chemistry, vol. 5, no. 2, pp. 81–89, 2015. View at Publisher · View at Google Scholar
  5. A. Hafner, J. Lovrić, G. P. Lakǒ, and I. Pepić, “Nanotherapeutics in the EU: An overview on current state and future directions,” International Journal of Nanomedicine, vol. 9, no. 1, article no. 1005, pp. 1005–1023, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Ulbrich, K. Holá, V. Šubr, A. Bakandritsos, J. Tuček, and R. Zbořil, “Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies,” Chemical Reviews, vol. 116, no. 9, pp. 5338–5431, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Gautier, E. Allard-Vannier, J. Burlaud-Gaillard, J. Domenech, and I. Chourpa, “Efficacy and hemotoxicity of stealth doxorubicin-loaded magnetic nanovectors on breast cancer xenografts,” Journal of Biomedical Nanotechnology, vol. 11, no. 1, pp. 177–189, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Lee, H. Kim, S. Kim et al., “A multifunctional mesoporous nanocontainer with an iron oxide core and a cyclodextrin gatekeeper for an efficient theranostic platform,” Journal of Materials Chemistry, vol. 22, no. 28, pp. 14061–14067, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. H.-L. Liu, M.-Y. Hua, H.-W. Yang et al., “Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 34, pp. 15205–15210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Aran, A. P. Victorino, L. C. Thuler, and C. G. Ferreira, “Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality,” Colorectal Cancer, vol. 15, pp. 195–203, 2016. View at Publisher · View at Google Scholar
  11. A. H. Shain and B. C. Bastian, “From melanocytes to melanomas,” Nature Reviews Cancer, vol. 16, no. 6, pp. 345–358, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. P. S. Steeg, “Targeting metastasis,” Nature Reviews Cancer, vol. 16, pp. 201–218, 2016. View at Publisher · View at Google Scholar
  13. G. P. Tuszynski and G. Cossu, “Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines,” Cancer Research, vol. 44, pp. 768–771, 1984. View at Google Scholar
  14. V. Amenta and K. Aschberger, “Carbon nanotubes: Potential medical applications and safety concerns,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 7, no. 3, pp. 371–386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Y. Madani, A. Mandel, and A. M. Seifalian, “A concise review of carbon nanotube’s toxicology,” Nano Reviews, vol. 4, no. 1, Article ID 21521, 2013. View at Publisher · View at Google Scholar
  16. http://bio-pact.com/mgmr/.
  17. S. Boncel, K. H. Müller, J. N. Skepper, K. Z. Walczak, and K. K. K. Koziol, “Tunable chemistry and morphology of multi-wall carbon nanotubes as a route to non-toxic, theranostic systems,” Biomaterials, vol. 32, no. 30, pp. 7677–7686, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Ali-Boucetta, A. Nunes, R. Sainz et al., “Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization,” Angewandte Chemie, vol. 52, no. 8, pp. 2274–2278, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. V. E. Kagan, A. A. Kapralov, C. M. St Croix et al., “Lung macrophages Digest carbon nanotubes using a superoxide/peroxynitrite oxidative pathway,” ACS Nano, vol. 8, no. 6, pp. 5610–5621, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Russier, C. Ménard-Moyon, E. Venturelli et al., “Oxidative biodegradation of single- and multi-walled carbon nanotubes,” Nanoscale, vol. 3, no. 3, pp. 893–896, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Bhattacharya, C. Sacchetti, R. El-Sayed et al., “Enzymatic 'stripping' and degradation of PEGylated carbon nanotubes,” Nanoscale, vol. 6, no. 24, pp. 14686–14690, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Fabbro, H. Ali-Boucetta, T. D. Ros, K. Kostarelos, A. Bianco, and M. Prato, “Targeting carbon nanotubes against cancer,” Chemical Communications, vol. 48, no. 33, pp. 3911–3926, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Pérez-Herrero and A. Fernández-Medarde, “Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 93, pp. 52–79, 2015. View at Publisher · View at Google Scholar
  24. Y. Kim, O. N. Torrens, J. M. Kikkawa, E. Abou-Hamad, C. Goze-Bac, and D. E. Luzzi, “High-purity diamagnetic single-wall carbon nanotube buckypaper,” Chemistry of Materials, vol. 19, no. 12, pp. 2982–2986, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Boncel, A. P. Herman, and K. Z. J. Walczak, “Magnetic carbon nanostructures in medicine,” Journal of Materials Chemistry, vol. 22, pp. 31–37, 2012. View at Publisher · View at Google Scholar
  26. A. Al Faraj, A. P. Shaik, and A. S. Shaik, “Magnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: Noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarker,” International Journal of Nanomedicine, vol. 10, pp. 157–168, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. M. A. Elhissi, W. Ahmed, I. U. Hassan, V. R. Dhanak, and A. D'Emanuele, “Carbon nanotubes in cancer therapy and drug delivery,” vol. 2012, Article ID 837327, 10 pages, 2012. View at Publisher · View at Google Scholar
  28. X. Fan and X. Li, “Preparation and magnetic property of multiwalled carbon nanotubes decorated by Fe3O4 nanoparticles,” New Carbon Mater, vol. 27, pp. 111–116, 2012. View at Google Scholar
  29. B. M. Maciejewska, L. E. Coy, K. K. K. Koziol, and S. Jurga, “Facile synthesis of highly stable and water-soluble magnetic MWCNT/α-Fe nanocomposites,” Journal of Physical Chemistry C, vol. 118, no. 48, pp. 27861–27869, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. K. Vashist, D. Zheng, G. Pastorin, K. Al-Rubeaan, J. H. T. Luong, and F.-S. Sheu, “Delivery of drugs and biomolecules using carbon nanotubes,” Carbon, vol. 49, no. 13, pp. 4077–4097, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Zhang, Z. Zhang, and Y. Zhang, “The application of carbon nanotubes in target drug delivery systems for cancer therapies,” Nanoscale Research Letters, vol. 6, no. 555, 2011. View at Publisher · View at Google Scholar
  32. A. A. Bhirde, V. Patel, J. Gavard et al., “Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery,” ACS Nano, vol. 3, no. 2, pp. 307–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. N. M. Dinan, F. Atyabi, M.-R. Rouini, M. Amini, A.-A. Golabchifar, and R. Dinarvand, “Doxorubicin loaded folate-targeted carbon nanotubes: Preparation, cellular internalization, in vitro cytotoxicity and disposition kinetic study in the isolated perfused rat liver,” Materials Science and Engineering C, vol. 39, no. 1, pp. 47–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Yu, L. Kong, L. Li, N. Li, and P. Yan, “Antitumor activity of doxorubicin-loaded carbon nanotubes incorporated poly(lactic-co-glycolic acid) electrospun composite nanofibers,” Nanoscale Research Letters, vol. 10, no. 343, 2015. View at Publisher · View at Google Scholar
  35. P. Das, C. K. Jain, S. K. Dey et al., “Synthesis, crystal structure, DNA interaction and in vitro anticancer activity of a Cu(ii) complex of purpurin: Dual poison for human DNA topoisomerase i and II,” RSC Advances, vol. 4, no. 103, pp. 59344–59357, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. J. K. Son, S. J. Jung, J. H. Jung et al., “Anticancer constituents from the roots of Rubia cordifolia L.,” Chemical and Pharmaceutical Bulletin, vol. 56, no. 2, pp. 213–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. O. Tacar, P. Sriamornsak, and C. R. Dass, “Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems,” Journal of Pharmacy and Pharmacology, vol. 65, no. 2, pp. 157–170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. D. B. Longley, D. P. Harkin, and P. G. Johnston, “5-Fluorouracil: mechanisms of action and clinical strategies,” Nature Reviews Cancer, vol. 3, no. 5, pp. 330–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Mehrotra, K. Misra, and R. K. Mishra, “Dna intercalation and photoinduced cleavage by 4-nitro(n-hexylamine)1,8-naphthalimide,” Nucleosides and Nucleotides, vol. 13, no. 4, pp. 963–978, 1994. View at Publisher · View at Google Scholar · View at Scopus
  40. M. F. Braña and A. Ramos, “Naphthalimides as anti-cancer agents: synthesis and biological activity,” Current Medicical Chemistry Anticancer Agents, vol. 1, no. 3, pp. 237–255, 2001. View at Publisher · View at Google Scholar
  41. W. Zhang, X. Qian, Y. Wu, and H. Ohrui, “A new class of dna intercalator and photocleaver: bis-naphthalimides with bromo and nitro substituents,” Heterocyclic Communications, vol. 9, pp. 229–234, 2011. View at Google Scholar
  42. S. Boncel, A. P. Herman, S. Budniok et al., “In vitro targeting and selective killing of T47D breast cancer cells by purpurin and 5-fluorouracil anchored to magnetic CNTs: nitrene-based functionalization versus uptake, cytotoxicity, and intracellular fate,” ACS Biomaterials Science and Engineering, vol. 2, no. 8, pp. 1273–1285, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Boncel, S. W. Pattinson, V. Geiser, M. S. P. Shaffer, and K. K. K. Koziol, “En route to controlled catalytic CVD synthesis of densely packed and vertically aligned nitrogen-doped carbon nanotube arrays,” Beilstein Journal of Nanotechnology, vol. 5, no. 1, pp. 219–233, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Boncel, K. K. K. Koziol, K. Z. Walczak, A. H. Windle, and M. S. P. Shaffer, “Infiltration of highly aligned carbon nanotube arrays with molten polystyrene,” Materials Letters, vol. 65, no. 14, pp. 2299–2303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. M. S. Dresselhaus, A. Jorio, A. G. S. Filho, and R. Saito, “Defect characterization in graphene and carbon nanotubes using Raman spectroscopy,” Philosophical Transactions of the Royal Society A, vol. 368, no. 1932, pp. 5355–5377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Boncel, M. Brzeziński, J. Mrowiec-Białoń, D. Janas, K. K. K. Koziol, and K. Z. Walczak, “Oxidised multi-wall carbon nanotubes-(R)-polylactide composite with a covalent β-d-uridine filler-matrix linker,” Materials Letters, vol. 91, pp. 50–54, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. J. F. Marco, J. R. Gancedo, A. Hernando et al., “Mössbauer study of iron-containing carbon nanotubes,” Hyperfine Interactions, vol. 139-140, no. 1-4, pp. 535–542, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Jamrozik, M. Mazurkiewicz, A. Małolepszy et al., “Mössbauer spectroscopy analysis of iron compounds in carboxylated multiwall carbon nanotubes and their ammonium salt,” Physica Status Solidi (A) Applications and Materials Science, vol. 208, no. 8, pp. 1783–1786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. K. K. K. Koziol, C. Ducati, and A. H. Windle, “Carbon nanotubes with catalyst controlled chiral angle,” Chemistry of Materials, vol. 22, no. 17, pp. 4904–4911, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Boncel, D. Osyda, and K. Z. Walczak, “N-1 regioselective Michael-type addition of 5-substituted uracils to (2-hydroxyethyl) acrylate,” Beilstein Journal of Organic Chemistry, vol. 3, article 40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. E. C. Vermisoglou, G. Pilatos, G. E. Romanos, E. Devlin, N. K. Kanellopoulos, and G. N. Karanikolos, “Magnetic carbon nanotubes with particle-free surfaces and high drug loading capacity,” Nanotechnology, vol. 22, no. 35, Article ID 355602, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. J. M. Tan, G. Karthivashan, P. Arulselvan, S. Fakurazi, and M. Z. Hussein, “Characterization and in vitro studies of the anticancer effect of oxidized carbon nanotubes functionalized with betulinic acid,” Drug Design, Development and Therapy, vol. 8, pp. 2333–2343, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Hu, T. Wang, X. Pei et al., “Synergistic enhancement of antitumor efficacy by PEGylated multi-walled carbon nanotubes modified with cell-penetrating peptide TAT,” Nanoscale Research Letters, vol. 11, p. 452, 2016. View at Publisher · View at Google Scholar
  54. S. Y. Madani, A. Tan, M. Dwek, and A. M. Seifalian, “Functionalization of single-walled carbon nanotubes and their binding to cancer cells,” International Journal of Nanomedicine, vol. 7, pp. 905–914, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Mahmood, Y. Xu, V. Dantuluri et al., “Carbon nanotubes enhance the internalization of drugs by cancer cells and decrease their chemoresistance to cytostatics,” Nanotechnology, vol. 24, no. 4, Article ID 045102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Alarifi, D. Ali, A. Verma, F. N. Almajhdi, and A. A. Al-Qahtani, “Single-walled carbon nanotubes induce cytotoxicity and DNA damage via reactive oxygen species in human hepatocarcinoma cells,” In Vitro Cellular and Developmental Biology - Animal, vol. 50, no. 8, pp. 714–722, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Roda, A. F. Castoldi, T. Coccini et al., “In vitro toxicity assessment of single- and multi-walled carbon nanotubes in human astrocytoma and lung carcinoma cells,” Toxicology Letters, vol. 172, pp. S235–S236, 2007. View at Publisher · View at Google Scholar
  58. O. Vittorio, V. Raffa, and A. Cuschieri, “Influence of purity and surface oxidation on cytotoxicity of multiwalled carbon nanotubes with human neuroblastoma cells,” Nanomedicine: Nanotechnology, Biology and Medicine, vol. 5, pp. 424–431, 2009. View at Google Scholar
  59. O. Wasielewski and M. Skonieczna, “Pleiotropic effects of the neuropeptides CCAP and myosuppressin in the beetle, Tenebrio molitor L.,” Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology, vol. 178, no. 7, pp. 877–885, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Cui, G. Yang, Z. Pan et al., “Hormetic response to low-dose radiation: focus on the immune system and its clinical implications,” International Journal of Molecular Sciences, vol. 18, no. 2, 280 pages, 2017. View at Publisher · View at Google Scholar
  61. A. Mielańczyk, M. Skonieczna, Ł. Mielańczyk, and D. Neugebauer, “In vitro evaluation of doxorubicin conjugates based on sugar core nonlinear polymethacrylates toward anticancer drug delivery,” Bioconjugate Chemistry, vol. 27, no. 4, pp. 893–904, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. P. Pozarowski and Z. Darzynkiewicz, “Analysis of cell cycle by flow cytometry,” in Checkpoint Controls and Cancer, A. H. Schönthal, Ed., vol. 281 of Methods in Molecular Biology, pp. 301–311, Humana Press, NJ, USA, 2004. View at Publisher · View at Google Scholar
  63. M. G. J. Ormerod, “Investigating the relationship between the cell cycle and apoptosis using flow cytometry,” Journal of Immunological Methods, vol. 265, pp. 73–80, 2002. View at Google Scholar
  64. P. Capella and J. Moll, “Assessment of cell cycle inhibitors by flow cytometry,” in Drug Discovery and Development—Present and Future, vol. 13, pp. 323–338, 2011. View at Google Scholar
  65. R. Górnicki, A. Błachowski, and K. Ruebenbauer, “Mössbauer Spectrometer MsAa-3,” Nukleonika, vol. 52, supplement 1, pp. S7–S12, 2007. View at Google Scholar